Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.08.25.671769

APDeeM: A machine Learning strategy towards Effective Peptide Vaccine Candidates Identification against Different Types of Viruses

Hossain, M. U.·Alom, M. R.·Hasan, S. S.·Sakib, M. N.·Suchi, M. A.·Sanjida, Z.·Rahman, A. B. Z. N.·Bhattacharjee, A.·Chowdhury, Z. M.·Ahammad, I.·Rahman, M. A.·Azad, S.·Salimullah, M.
View original source ↗Export metadata ↓

Abstract

Viral infections pose significant global health challenges, underscoring the urgent need for improved medications. Nevertheless, traditional medicinal approaches depend significantly on labor-intensive laboratory tests, which impede efficient identification and prolong vaccine development, particularly when screening a huge number of samples. To address these obstacles, we present a comprehensive Antiviral Peptide (AVP) Detection Dataset, comprising 14 unique features to improve the characterization of antiviral and non-antiviral peptides. Subsequently, we introduce the Antiviral Peptide detection enhanced by Ensemble Machine Learning (APDeeM) system. This advanced computational framework considerably reduces the time required for AVP detection by utilizing ensemble learning methodologies. The APDeeM system incorporates Gradient Boosting, Random Forest, K-Nearest Neighbors (KNN), and AdaBoost algorithms to facilitate the swift selection of AVP candidates without requiring urgent laboratory testing. Our proposed ensemble methodology showed superior performance, with an accuracy of 85.99%, F1 score of 87.60%, recall of 88.91%, and precision of 86.32%, exceeding the efficacy of all tested antiviral peptide prediction models in this research. The APDeeM approach signifies a substantial improvement over conventional detection techniques, expediting the identification of prospective vaccine candidates and facilitating the advancement of more effective antiviral peptides. The most promising AVP candidates may urge laboratory validation, optimize resources, and accelerate vaccine development.

Explore related subjects

bioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hossain, M. U., Alom, M. R., Hasan, S. S., Sakib, M. N., Suchi, M. A., Sanjida, Z., Rahman, A. B. Z. N., Bhattacharjee, A., Chowdhury, Z. M., Ahammad, I., Rahman, M. A., Azad, S., Salimullah, M.. 2025-08-28. APDeeM: A machine Learning strategy towards Effective Peptide Vaccine Candidates Identification against Different Types of Viruses. https://doi.org/10.1101/2025.08.25.671769

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Mapping Gene Expression to an Interpretable Semantic Space

Cell embeddings organize single-cell expression data, but their dimensions have no biological meaning, so clusters are interpreted afterward. We present MESIC (Mapping Expression to Semantic space with Interpretable Components), which builds the written knowledge about genes held in curated databases into the dimensions themselves. A biomedical language model converts each gene's summary into a semantic embedding. MESIC compresses these embeddings into a small number of components, each concentrated on a small set of genes and explained by their annotations. The components are computed once from the summaries, so any expression dataset can be mapped onto them, and every cluster, outlier, or cell-type assignment is then characterized by named genes. In cardiomyocytes, outliers in the component space were enriched for hypertrophic cardiomyopathy. In a lung atlas, unsupervised clusters in that space matched the broad cell types that experts had annotated. In both, the components that separated the cells matched their known biology. For about half of the cells that the atlas itself had left unannotated, the same space gave a confident cluster assignment, and with it an interpretation through component-associated genes. Gene summaries thus give single-cell analysis a coordinate system in which every result is traced to genes and what is written about them.

bioinformatics↗
bioRxiv2026

Physical priors improve performance of structure-based binding affinity models

Structure-based drug discovery is a widely used paradigm for the rational design of novel small molecule therapeutics. However, the benefits conferred by the use of structural information has seen limited adoption in machine learning, where ligand-only ("2D") models are still the industry standard for molecular property or binding affinity prediction. Structure-based ("3D") ML models for binding-affinity prediction promise to present a clear advantage, but have not yet overtaken existing 2D models. Here, we show that physics-based priors can improve predictive performance of structure-based models by comparing different model architectures with varying physical priors on several prediction tasks. We present the Modular Training and Evaluation of Neural Networks (mtenn) package, where we decompose affinity prediction into separate steps of embedding structure into learned representations and combining those embeddings into a predicted binding affinity. We consider both E(3)-invariant and E(3)-equivariant architectures to determine the importance of encoding roto-translational inductive biases, as well as different methods for combining learned embeddings. By first optimizing several aspects of model construction using the general purpose PDBBind dataset, we are able to improve the performance and data efficiency of structure-based models. When subsequently trained and evaluated on the COVID Moonshot small molecule drug discovery dataset, our tuned models perform on par with industry standard ligand-only models. Our decomposed model framework highlights that encoding some physical priors improves model performance, while more complex biases such as equivariance offer limited benefit. Additionally, structure-based models generalize better to an unseen target and display higher training efficiency. Overall, these results emphasize that structure-based models benefit from their ability to incorporate physics-informed constraints, giving promising directions for model architecture development. These results also suggest that the strength of these models may be in tasks specifically aimed at generalizability, providing guidelines for their use in early-stage drug discovery campaigns.

bioinformatics↗
bioRxiv2026

Rapid Shift Toward Pulsed Field Ablation and Precision Risk Stratification in High-Impact Atrial Fibrillation Research

Conventional bibliometrics rely on lifetime citations, obscuring immediate shifts in cardiovascular research paradigms. To track emerging trends in atrial fibrillation management, we performed a comparative bibliometric analysis of the 50 highest-cited original research articles per year in OpenAlex topic T10065 across consecutive 2023 (Class of 2025) and 2024 (Class of 2026) publication cohorts. Articles were ranked using a fixed 18-month post-publication citation window, and extracted concepts were normalized into 719 canonical topics and 32 parent themes using large language model curation. Concept frequency tracking demonstrated a swift technological shift, with pulsed field ablation showing the largest topic frequency increase (+0.08, from 0.30 to 0.38) to become the leading canonical topic in 2024, displacing conventional thermal pulmonary vein isolation (-0.18, 0.40 to 0.22). Simultaneously, stroke prevention focus shifted toward refined predictive modeling, with increases in Risk Stratification and Predictive Models (+0.08, 0.30 to 0.38) and CHA2DS2-VASc scoring (+0.08, from 0.10 to 0.18). High-impact atrial fibrillation research is rapidly pivoting toward non-thermal ablation safety profiling and precision risk stratification, highlighting the utility of fixed-window concept mining for capturing real-time scientific evolution. Online explorer of the result is available at https://pri.pepkio.com.

bioinformatics↗